SK279907B6 - 1r-cis,1'r-cis-2,2'-(3,11-dioxo-4,10-dioxotridecyl - Google Patents

1r-cis,1'r-cis-2,2'-(3,11-dioxo-4,10-dioxotridecyl Download PDF

Info

Publication number
SK279907B6
SK279907B6 SK3833-92A SK383392A SK279907B6 SK 279907 B6 SK279907 B6 SK 279907B6 SK 383392 A SK383392 A SK 383392A SK 279907 B6 SK279907 B6 SK 279907B6
Authority
SK
Slovakia
Prior art keywords
cis
dioxo
salt
dimethoxy
tetrahydro
Prior art date
Application number
SK3833-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK383392A3 (en
Inventor
Derek A. Hill
Geoffrey L. Turner
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of SK279907B6 publication Critical patent/SK279907B6/sk
Publication of SK383392A3 publication Critical patent/SK383392A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Led Devices (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paper (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
SK3833-92A 1990-07-13 1991-07-12 1r-cis,1'r-cis-2,2'-(3,11-dioxo-4,10-dioxatridecylene)-bis- -(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1- -veratrylisoquinolinium salt, preparation method thereof, pharmaceutical composition comprising the same and its use SK383392A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909015473A GB9015473D0 (en) 1990-07-13 1990-07-13 Neuromuscular blocking agents
PCT/GB1991/001150 WO1992000965A1 (fr) 1990-07-13 1991-07-12 Agents de blocage neuromusculaire

Publications (2)

Publication Number Publication Date
SK279907B6 true SK279907B6 (sk) 1999-05-07
SK383392A3 SK383392A3 (en) 1999-05-07

Family

ID=10679071

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3833-92A SK383392A3 (en) 1990-07-13 1991-07-12 1r-cis,1'r-cis-2,2'-(3,11-dioxo-4,10-dioxatridecylene)-bis- -(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1- -veratrylisoquinolinium salt, preparation method thereof, pharmaceutical composition comprising the same and its use

Country Status (40)

Country Link
EP (1) EP0539470B1 (fr)
JP (3) JP2823356B2 (fr)
KR (1) KR0174284B1 (fr)
AT (1) ATE138369T1 (fr)
AU (2) AU8190491A (fr)
BE (1) BE1003407A3 (fr)
CA (1) CA2087104C (fr)
CH (1) CH683427A5 (fr)
CY (1) CY1985A (fr)
CZ (1) CZ284645B6 (fr)
DE (2) DE4191541T1 (fr)
DK (2) DK0539470T3 (fr)
ES (2) ES2088009T3 (fr)
FI (2) FI103507B1 (fr)
FR (1) FR2665701B1 (fr)
GB (2) GB9015473D0 (fr)
GE (1) GEP19981163B (fr)
GR (1) GR3020792T3 (fr)
HK (1) HK80196A (fr)
HU (2) HU218766B (fr)
IE (1) IE912440A1 (fr)
IL (1) IL98814A (fr)
IT (1) IT1249677B (fr)
LT (1) LT3317B (fr)
LU (1) LU88198A1 (fr)
LV (1) LV10432B (fr)
MX (1) MX9203220A (fr)
MY (1) MY113017A (fr)
NL (1) NL9120017A (fr)
NZ (1) NZ238964A (fr)
PA (1) PA8401801A1 (fr)
PL (1) PL167302B1 (fr)
PT (1) PT98306B (fr)
RU (1) RU2104005C1 (fr)
SA (1) SA91120073B1 (fr)
SE (1) SE9300052L (fr)
SK (1) SK383392A3 (fr)
UA (1) UA32536C2 (fr)
WO (1) WO1992000965A1 (fr)
ZA (1) ZA915468B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
DE19535762A1 (de) * 1995-09-26 1997-03-27 Basf Ag Verfahren zur Racematspaltung
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
CA2284802C (fr) * 1997-03-25 2009-06-16 Cornell Research Foundation, Inc. Isoquinoleines substituees en tant qu'inhibiteurs neuromusculaires exercant une action extremement courte
AU2008222298A1 (en) 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
AU2008231470A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
WO2008132748A1 (fr) 2007-05-01 2008-11-06 Chemagis Ltd. Procédé de fabrication de composés de cisatracurium et intermédiaires associés
WO2008132746A1 (fr) 2007-05-01 2008-11-06 Chemagis Ltd. Nouveaux composés d'isoquinolinium utiles dans la préparation de cisatracurium et intermédiaires associés
CA2687157A1 (fr) * 2007-06-18 2008-12-24 Chemagis Ltd. Procede de separation de sels de (1r,1'r)-atracurium
CN101337935B (zh) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 一种用两相萃取法纯化苯磺酸阿曲库铵的方法
CN101337936B (zh) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 一种用柱色谱法纯化苯磺酸阿曲库铵的方法
BRPI0816519A2 (pt) 2007-10-29 2015-03-24 Chemagis Ltd Processo para preparar um sal de r, r'-atracúrio isomericamente enriquecido e sal de r, r'-atracúrio
IT1396543B1 (it) 2008-07-16 2012-12-14 Farmabios Spa Processo per la purificazione di bloccanti neuromuscolari
WO2010128518A2 (fr) * 2009-05-04 2010-11-11 Gland Pharma Limited Nouveau procédé pour la préparation de bésylate de cisatracurium
CN107056700A (zh) * 2017-04-18 2017-08-18 哈尔滨医科大学 一种四氢异喹啉类化合物外消旋体的半量拆分法
CN112939862B (zh) * 2021-02-03 2023-01-10 江苏诚信药业有限公司 一种苯磺顺阿曲库铵杂质h的分离制备方法及其应用
CN115850169A (zh) * 2022-10-17 2023-03-28 上海医药集团(本溪)北方药业有限公司 苯磺顺阿曲库铵杂质及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
GB1579822A (en) * 1976-10-29 1980-11-26 Wellcome Found Tetrahydroisoquinolinium muscle relaxants
ES454090A1 (es) * 1976-12-09 1978-01-16 Wellcome Found Un metodo para preparar compuestos heterociclicos.
DE3328664A1 (de) * 1983-08-09 1985-02-21 Robert Bosch Gmbh, 7000 Stuttgart Zuckerziehmaschine
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation

Also Published As

Publication number Publication date
SA91120073B1 (ar) 2002-10-26
IE912440A1 (en) 1992-01-15
RU2104005C1 (ru) 1998-02-10
LTIP274A (en) 1994-10-25
MX9203220A (es) 1992-07-01
FI103507B (fi) 1999-07-15
HU218766B (hu) 2000-11-28
HU9300052D0 (en) 1993-04-28
GB9224764D0 (en) 1993-02-03
ITRM910518A0 (it) 1991-07-12
LU88198A1 (fr) 1993-05-17
ITRM910518A1 (it) 1992-01-14
KR0174284B1 (ko) 1999-02-18
JP2823356B2 (ja) 1998-11-11
DE4191541T1 (de) 1993-05-13
MY113017A (en) 2001-11-30
FI103507B1 (fi) 1999-07-15
FI982342A (fi) 1998-10-28
AU1134695A (en) 1995-03-30
GB2260763A (en) 1993-04-28
ZA915468B (en) 1993-03-31
IT1249677B (it) 1995-03-09
DK149692A (da) 1992-12-14
SK383392A3 (en) 1999-05-07
DK149692D0 (da) 1992-12-14
GB9015473D0 (en) 1990-08-29
CA2087104C (fr) 1998-08-18
ES2083315A1 (es) 1996-04-01
ES2088009T3 (es) 1996-08-01
PT98306A (pt) 1992-06-30
GEP19981163B (en) 1998-07-06
EP0539470A1 (fr) 1993-05-05
AU8190491A (en) 1992-02-04
UA32536C2 (uk) 2001-02-15
HU211169A9 (en) 1995-11-28
SE9300052D0 (sv) 1993-01-12
PA8401801A1 (es) 1997-01-03
NL9120017A (nl) 1993-04-01
FI925894A0 (fi) 1992-12-28
FI982342A0 (fi) 1998-10-28
HK80196A (en) 1996-05-17
PL297606A1 (fr) 1992-07-13
DE69119768D1 (de) 1996-06-27
FI925894A (fi) 1992-12-28
JPH05508648A (ja) 1993-12-02
FR2665701A1 (fr) 1992-02-14
LT3317B (en) 1995-06-26
JP2001058981A (ja) 2001-03-06
CA2087104A1 (fr) 1992-01-14
NZ238964A (en) 1992-06-25
CZ284645B6 (cs) 1999-01-13
SE9300052L (sv) 1993-01-12
HUT67613A (en) 1995-04-28
CY1985A (en) 1997-09-05
PT98306B (pt) 1999-01-29
FR2665701B1 (fr) 1995-03-03
EP0539470B1 (fr) 1996-05-22
AU687481B2 (en) 1998-02-26
DE69119768T2 (de) 1996-10-02
DK0539470T3 (da) 1996-08-05
IL98814A0 (en) 1992-07-15
CH683427A5 (fr) 1994-03-15
ATE138369T1 (de) 1996-06-15
ES2083315B1 (es) 1997-11-16
IL98814A (en) 1995-12-08
WO1992000965A1 (fr) 1992-01-23
LV10432B (en) 1995-08-20
CZ383392A3 (en) 1994-02-16
JPH10139763A (ja) 1998-05-26
LV10432A (lv) 1995-02-20
BE1003407A3 (fr) 1992-03-17
PL167302B1 (en) 1995-08-31
GR3020792T3 (en) 1996-11-30
GB2260763B (en) 1994-01-05
JP3462165B2 (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
US5453510A (en) Neuromuscular blocking agents
SK279907B6 (sk) 1r-cis,1'r-cis-2,2'-(3,11-dioxo-4,10-dioxotridecyl
DE69830157T2 (de) Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker
FI85019C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (e)-4-oktendioylbis (oxitrimetylen) bis (1,2,3,4-tetrahydro-6,7-dimetoxi-2-metyl-1-(3,4,5-trimetoxibensyl) isokinolinium) foereningar.
JPS6043342B2 (ja) イソキノリニウム化合物
US5506257A (en) Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
US4491665A (en) Method of preparing isomers of bis isoquinolinium compounds
DE69311896T2 (de) Aminocyclohexylamide für antiarrhythmische und anästhetische verwendungen
PL207995B1 (pl) Związki 3-fenylo-3,7-diazabicyklo[3,3,1]nonanu, środki lecznicze zawierające te związki, zastosowanie tych związków oraz sposób ich wytwarzania

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20110712